Shanghai
Search
-
AllBright assisted Ziroom in formation of a JV with Invesco
202502-25
-
ABL Advises on RMB 8.5 Billion Relief Financing for Bund Dongjiadu Project in Shanghai
202303-30
-
AllBright Advises Albemarle on Acquisition of Guangxi Tianyuan
202110-01
-
AllBright assists JMC in selling heavy truck business to Volvo Truck
202108-24
-
We are pleased to announce the opening of our AllBright US office.
202007-30
-
Allbright represents Yongfeng Group and Ningbo Taihong to acquire the control right of listed company Fulin Transportation (002357)
Recently, on behalf of Yongfeng Group Co., Ltd. (“Yongfeng Group”) and Ningbo Taihong Enterprise Management Co., Ltd. (“Ningbo Taihong”), Allbright provided full legal services for its acquisition of the control right of Sichuan Fulin Transportation Group Co.,Ltd. (“Fulin Transportation” or “Listed Company”, securities code: 002357).
201812-26
-
Allbright assists Dana Holding Corporation in completing major cross-border restructuring projects
At the end of June 2018, the cross-border reorganization project between Dana Holding Corporation and Taiwan Yulon Group/China Motors, which was handled by Allbright, was officially completed, with a transaction value of more than one billion dollars.
201807-13
-
AllBright lawyers as legal counsel advising global healthcare giant Grifols for the incorporation of plasma collection companies jointly with Boya
201805-14
-
Allbright assists China’s largest Internet auto insurance platform in completing over RMB100 million of B-round financing
In early September 2017, China’s largest Internet auto insurance platform “Zuihuibao” (Shanghai Zuihuibao Network Technology Co., Ltd.) successfully completed RMB 100 million B-round and B+-round of financing. The B round investment was led byShenzhen Capital Group Co., Ltd. (“Shenzhen Venture Capital”) and co-invested by Anhui Radio Film&TV Media Industry Group (“Anhui Radio & TV”); the B+ round was invested by Jiuyou Innovation Equity Fund.
201709-07
-
Allbright assists CF Pharm Tech, Inc. in completing RMB 440 million D-round financing
In August, 2017, CF PharmTech, Inc. successfully completed the D-round financing in amount of RMB 440 million.
201708-29
